Stem cell markers predict prognosis in breast cancer overall (EpCAM), and in subgroups of large (CD133), triple-negative (CD44), and hormone receptor positive carcinomas (CD166)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Lübeck, Universität zu Lübeck, Dissertation, 2021
- Keyword
-
Breast--Cancer
Prognosis
- Event
-
Veröffentlichung
- (where)
-
Lübeck
- (who)
-
Zentrale Hochschulbibliothek Lübeck
- (when)
-
2022
- Creator
-
Alkemade, Hendrik
- Contributor
-
Habermann, Jens K.
- URN
-
urn:nbn:de:gbv:841-20211028404
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alkemade, Hendrik
- Habermann, Jens K.
- Zentrale Hochschulbibliothek Lübeck
Time of origin
- 2022
Other Objects (12)
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater
EpCAM is critical for tumor proliferation and oxaliplatin chemoresistance in EpCAM high/CD44 + colorectal cancer stem cells
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
Expression der Stammzellmarker CD133, CD44, Ki-A10 und CK19 in nichtneoplastischen und neoplastischen Pankreasgeweben
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas
Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
A novel nitidine chloride nanoparticle overcomes the stemness of CD133+EPCAM+ Huh7 hepatocellular carcinoma cells for liver cancer therapy
CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma
Gegenseitige Beeinflussung von CD24, CD44 und CD133 in humanen Kolonkarzinomzellen und ihre Bedeutung für die spontane Metastasierung im Xenograftmodell
Membrane-bound prominin-1-CD133 concentrations in patients with various subgroups of epilepsy, as compared to healthy adults
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater
EpCAM is critical for tumor proliferation and oxaliplatin chemoresistance in EpCAM high/CD44 + colorectal cancer stem cells
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
Expression der Stammzellmarker CD133, CD44, Ki-A10 und CK19 in nichtneoplastischen und neoplastischen Pankreasgeweben
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas
Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
A novel nitidine chloride nanoparticle overcomes the stemness of CD133+EPCAM+ Huh7 hepatocellular carcinoma cells for liver cancer therapy
CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma
Gegenseitige Beeinflussung von CD24, CD44 und CD133 in humanen Kolonkarzinomzellen und ihre Bedeutung für die spontane Metastasierung im Xenograftmodell
Membrane-bound prominin-1-CD133 concentrations in patients with various subgroups of epilepsy, as compared to healthy adults
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater
EpCAM is critical for tumor proliferation and oxaliplatin chemoresistance in EpCAM high/CD44 + colorectal cancer stem cells
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
Expression der Stammzellmarker CD133, CD44, Ki-A10 und CK19 in nichtneoplastischen und neoplastischen Pankreasgeweben
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas
Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
A novel nitidine chloride nanoparticle overcomes the stemness of CD133+EPCAM+ Huh7 hepatocellular carcinoma cells for liver cancer therapy
CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma
Gegenseitige Beeinflussung von CD24, CD44 und CD133 in humanen Kolonkarzinomzellen und ihre Bedeutung für die spontane Metastasierung im Xenograftmodell